Abbott

On Thursday, Piper Sandler began covering Abbott Laboratories (NYSE:NYSE:) stock, assigning an Overweight rating and a $131 price target. The company highlighted the company’s strong performance, but noted that the stock has…

LPETT Update at 8:10 PM: Damage update, adds Abbott's comment. Abbott Laboratories (New York:ABT) decreased by 5% In after-hours trading after a St. Louis jury awarded a plaintiff $495 million in damages and penalties over allegations…

Abbott Park, Illinois - Abbott Laboratories The American healthcare company (NYSE:) reported second-quarter earnings that beat Wall Street expectations and raised its full-year adjusted earnings guidance, signaling confidence in its…

Breadcrumbs Path LinksPMN BusinessTexas Gov. Greg Abbott responded to President Joe Biden's claim that he had difficulty tracking down emergency funds for hurricane relief, saying the claim was "completely false and outlandish."Article…

Investing.com - Abbott Labs (NYSE:) reported second-quarter earnings per share of $1.08, $0.03 better than analyst estimates of $1.05. Revenue for the quarter came in at $10 billion versus the consensus estimate of $9.69 billion.…

Stereotaxic imaging (STXS) and Abbott's combine techniques into integrated procedures for the treatment of patients with arrhythmias stereoscopic (NYSE:), the leading and world-leading manufacturer of minimally invasive…